We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$880B
AUM Growth
+$147B
Cap. Flow
+$97B
Cap. Flow %
11.02%
Top 10 Hldgs %
14.5%
Holding
8,205
New
199
Increased
3,814
Reduced
2,948
Closed
311

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.71B
2
MSFT icon
Microsoft
MSFT
+$3.52B
3
AMZN icon
Amazon
AMZN
+$2.04B
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.87B
5
LLY icon
Eli Lilly
LLY
+$1.31B

Sector Composition

Rank Sector Weight
1 Technology 17.3%
2 Healthcare 12.11%
3 Financials 10.63%
4 Consumer Discretionary 8.09%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGG
6576
DELISTED
iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN
SGG
$13.9K ﹤0.01%
220
LIVE icon
6577
Live Ventures
LIVE
$31.8M
$13.9K ﹤0.01%
443
-27
-6% -$679
INZY
6578
DELISTED
Inozyme Pharma
INZY
$13.8K ﹤0.01%
13,146
-9,138
-41% -$16K
NERV icon
6579
Minerva Neurosciences
NERV
$206M
$13.8K ﹤0.01%
8,675
-4,944
-36% -$21.4K
CVV icon
6580
CVD Equipment Corp
CVV
$54.3M
$13.8K ﹤0.01%
2,497
-5
-0.2% -$28
SALM
6581
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$13.7K ﹤0.01%
13,043
PPSI
6582
Pioneer Power Solutions
PPSI
$32.7M
$13.7K ﹤0.01%
5,103
-1,498
-23% -$4.33K
EPHYU
6583
DELISTED
Epiphany Technology Acquisition Corp. Unit
EPHYU
$13.7K ﹤0.01%
1,367
LVWR.WS icon
6584
LiveWire Group Warrants
LVWR.WS
$6.66M
$13.6K ﹤0.01%
49,473
TRML
6585
DELISTED
Tourmaline Bio
TRML
$13.6K ﹤0.01%
1,334
-585
-30% -$9.4K
FID icon
6586
First Trust Exchange-Traded Fund VI First Trust S&P International Dividend Aristocrats ETF
FID
$170M
$13.6K ﹤0.01%
886
LDEM icon
6587
iShares ESG MSCI EM Leaders ETF
LDEM
$33.2M
$13.6K ﹤0.01%
+318
New +$13.6K
DWAT
6588
DELISTED
Arrow Investments Trust Arrow DWA Tactical ETF
DWAT
$13.5K ﹤0.01%
1,300
RGF
6589
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
$13.5K ﹤0.01%
+170
New +$13.9K
SNT
6590
Senstar Technologies
SNT
$44.8M
$13.5K ﹤0.01%
10,708
ROKT icon
6591
State Street SPDR S&P Kensho Final Frontiers ETF
ROKT
$216M
$13.5K ﹤0.01%
342
ILAG icon
6592
Intelligent Living
ILAG
$6.6M
$13.4K ﹤0.01%
+1,521
New +$34.9K
SWAN icon
6593
Amplify BlackSwan Growth & Treasure Core ETF
SWAN
$161M
$13.3K ﹤0.01%
546
+319
+141% +$7.98K
RMTI icon
6594
Rockwell Medical
RMTI
$27.9M
$13.3K ﹤0.01%
1,312
-19
-1% -$203
FBCG
6595
Fidelity Blue Chip Growth ETF
FBCG
$7.21B
$13.2K ﹤0.01%
625
-465
-43% -$10.3K
EBON icon
6596
Ebang International Holdings
EBON
$13.2M
$13.2K ﹤0.01%
4,521
-804
-15% -$5.93K
HYBB icon
6597
iShares BB Rated Corporate Bond ETF
HYBB
$427M
$12.9K ﹤0.01%
291
JG
6598
Aurora Mobile
JG
$29.8M
$12.9K ﹤0.01%
1,006
MPTI icon
6599
M-tron Industries
MPTI
$370M
$12.9K ﹤0.01%
+1,469
New +$15.1K
CIA icon
6600
Citizens
CIA
$188M
$12.8K ﹤0.01%
6,031
-108,638
-95% -$303K

Similar funds

Morgan Stanley's Q4 2022 Portfolio in Review

As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.

  • Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
  • Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
  • Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
  • Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
  • Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
  • Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
  • Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.